| Literature DB >> 27672318 |
D Eschbach1, T Kirchbichler1, T Wiesmann2, L Oberkircher1, C Bliemel1, S Ruchholtz1, B Buecking1.
Abstract
BACKGROUND: Most studies focusing on improving the nutritional status of geriatric trauma patients exclude patients with cognitive impairment. These patients are especially at risk of malnutrition at admission and of worsening during the perioperative fasting period. This study was planned as a feasibility study to identify the difficulties involved in including this high-risk collective of cognitively impaired geriatric trauma patients. PATIENTS AND METHODS: This prospective intervention study included cognitively impaired geriatric patients (Mini-Mental State Examination <25, age >65 years) with hip-related fractures. We assessed Mini Nutritional Assessment (MNA), Nutritional Risk Screening (NRS 2002), body mass index, calf circumference, American Society of Anesthesiologists' classification, and Braden Scale. All patients received parenteral nutritional supplementation of 800 kcal/d for the 96-hour perioperative period. Serum albumin and pseudocholinesterase were monitored. Information related to the study design and any complications in the clinical course were documented.Entities:
Keywords: cognitive impaired geriatric trauma patients; elderly; malnutrition; perioperative nutrition management
Year: 2016 PMID: 27672318 PMCID: PMC5026212 DOI: 10.2147/CIA.S109281
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Baseline data
| ID | Age (years) | Sex | ASA | MMSE | BMI (kg/m2) | CC (cm) | MNA | NRS 2002 | BI-A |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 89 | F | 4 | 9 | 20.8 | 32 | 12 | 3 | 35 |
| 2 | 78 | F | 3 | 10 | 26.3 | 33.5 | 16 | 3 | 40 |
| 3 | 82 | M | 3 | 20 | 29.9 | 36 | 17 | 3 | 70 |
| 4 | 82 | M | 3 | 0 | 20.3 | 28 | 6.5 | 3 | 20 |
| 5 | 77 | F | 3 | 10 | 23.4 | 25 | 7.5 | 3 | 40 |
| 6 | 80 | F | 3 | 7 | 24 | 29 | 14 | 2 | 35 |
| 7 | 90 | F | 4 | 24 | 18 | 20 | 10 | 3 | 55 |
| 8 | 91 | F | 4 | 20 | 12.9 | 18 | 13 5 | 60 | |
| 9 | 87 | M | 3 | 15 | 25.1 | – | 14.5 | 3 | 85 |
| 10 | 87 | F | 3 | 3 | 27.3 | 31 | 10.5 | 3 | 50 |
| 11 | 75 | F | 3 | 15 | 15.5 | 19 | 10 | 5 | 40 |
| 12 | 82 | M | 3 | 5 | – | 28 | 24.5 | 2 | 80 |
| 13 | 73 | M | 4 | 4 | 22.9 | 34 | 13 | 2 | 20 |
| 14 | 88 | M | 3 | 2 | 27 | 31 | 16.5 3 | 35 | |
| 15 | 86 | F | 2 | 9 | 26.3 | 31 | 18.5 | 2 | 25 |
| 16 | 89 | F | 3 | 1 | 25 | – | 16 | 3 | 40 |
| 17 | 85 | M | 3 | 0 | 22.5 | 30 | 12 | 1 | 55 |
| 18 | 74 | F | 3 | 10 | 18.3 | 29 | 11 | 3 | 65 |
| 19 | 89 | M | 3 | 21 | 26.5 | 34.5 | 23.5 | 2 | 95 |
| 20 | 81 | M | 3 | 16 | 22.5 | 29 | 18.5 | 3 | 35 |
Notes: Gray-shaded fields highlight patients who did not survive in patient stay. “–” Indicates missing value.
Abbreviations: ASA, American Society of Anesthesiologists; MMSE, Mini–Mental State Examination; BMI, body mass index; CC, calf circumference; MNA, Mini Nutritional Assessment; NRS 2002, Nutritional Risk Score; BI-A, Barthel Index at admission; F, female; M, male.
Analytical separation of complications
| Complication | Number of patients |
|---|---|
| Pleural effusion | 2 |
| Urinary tract infection | 5 |
| NSTEMI | 1 |
| Pneumonia | 2 |
| Pneumothorax | 1 |
| 1 | |
| Anemia | 2 |
| Death | 2 |
Note:
Same patient.
Abbreviation: NSTEMI, non-ST-segment elevation myocardial infarction.
Figure 1(A) Median albumin levels at admission; at days 2, 3, and 4 of nutritional supplementation; and at discharge. (B) Median PCHE = PCHE at admission and discharge.
Notes: Data are given as median and quartiles. *P≤0.05.
Abbreviation: PCHE, pseudocholinesterase.
Analytical data of serological parameters
| Albumin (mg/dL) | Median | Range | PCHE (U/L) | Median | Range | Triglycerides (mmol/L) | Median | Range |
|---|---|---|---|---|---|---|---|---|
| Admission | 34 | 18–41 | Admission | 4,965 | 2,020–7,991 | Admission | 77 | 42–251 |
| Day 2 | 28 | 20–35 | Day 2 | – | – | Day 2 | 73 | 28–436 |
| Day 3 | 26 | 22–32 | Day 3 | – | – | Day 3 | 82 | 40–381 |
| Day 4 | 26 | 22–32 | Day 4 | – | – | Day 4 | 78 | 42–187 |
| Discharge | 29 | 29–31 | Discharge | 4,065 | 1,910–5,945 | Discharge | 106 | 54–186 |
Notes: PCHE was measured only at admission and discharge.
Both amounts were measured in the same patient. “–” Indicates no planned blood analysis.
Abbreviation: PCHE, pseudocholinesterase.
Outcome scores
| Test | Item | Results |
|---|---|---|
| TUG test | Possible | 1 patient –7 seconds |
| Not possible | 19 | |
| Mobilization | 0. No mobilization | 2 |
| 1. Sitting | 3 | |
| 2. Standing | 7 | |
| 3. Walking | 7 | |
| 4. Climbing stairs | 1 | |
| NMS, median/range | 0.5 (0–5) | |
| BS | ≥10 points | 2 |
| 6–9 points | 18 |
Abbreviations: TUG, Timed Up and Go; NMS, new mobility score for in-hospital outcome; BS, Braden Scale.